Healthcare & Life Sciences
Context Therapeutics
United Statescontexttherapeutics.com
Context Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
1
Investors
About Context Therapeutics
Based in the United States, Context Therapeutics is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Context Therapeutics develops clinical-stage bispecific T cell engager antibody therapies targeting solid tumors to activate the immune system for cancer treatment.
Explore Context Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.